Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Operating Expenses (2014 - 2026)

Updated

Evofem Biosciences' Operating Expenses was $5.12 million in Q2 2026, down 15.7% from $6.08 million a year earlier and down 6.3% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Operating Expenses (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Evofem Biosciences' Operating Expenses was $20.81 million through Jun 30, 2026, down 3.8% year-over-year; for FY2025, it came in at $16.81 million, down 37.8% from FY2024.

  • Operating Expenses has now declined for four consecutive years, with a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $27.04 million in FY2024 (-25.0%), $36.07 million in FY2023 (-64.3%), $100.96 million in FY2022 (-42.3%) and $175.05 million in FY2021 (+68.2%).
  • Quarterly Operating Expenses has moved between $518,000 (Q1 2025) and $45.08 million (Q3 2021) over five years.
  • Compared with a year earlier, Operating Expenses was higher in two of the last eight quarters, with growth averaging 96.3%.
  • The best year-over-year quarter for Operating Expenses over five years was Q1 2026 (growth of 955.6%); the worst was Q1 2025 (a decline of 92.0%).
  • Per Business Quant data, EVFM's Operating Expenses in the three quarters before Q2 2026 was $5.47 million (Q1 2026), $6.22 million (Q4 2025) and $4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 10.12 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 10.56 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 9.70 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn 18.20 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 6.68 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn 5.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.12 Mn
Mar 31, 2026 5.47 Mn
Dec 31, 2025 6.22 Mn
Sep 30, 2025 4.00 Mn
Jun 30, 2025 6.08 Mn
Mar 31, 2025 518,000.00
Dec 31, 2024 8.11 Mn
Sep 30, 2024 6.94 Mn
Jun 30, 2024 5.55 Mn
Mar 31, 2024 6.45 Mn
Dec 31, 2023 8.22 Mn
Sep 30, 2023 8.66 Mn
Jun 30, 2023 9.79 Mn
Mar 31, 2023 9.39 Mn
Dec 31, 2022 12.23 Mn
Sep 30, 2022 25.10 Mn
Jun 30, 2022 30.45 Mn
Mar 31, 2022 33.18 Mn
Dec 31, 2021 40.99 Mn
Sep 30, 2021 45.08 Mn
API Access

Evofem Biosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=EVFM&period=max&api_key=YOUR_API_KEY